Search results - ORA - Oxford University Research Archive

1 - 17 of 17

1

Journal article

PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.

Sharp, C, Gregory, W, Hattingh, L, et al.
2017-04-17

2

Journal article

Hepatitis C Virus (HCV) diagnosis and access to treatment in a UK cohort

Adland, E, Jesuthasan, G, Downs, L, et al.
2018-09-14

3

Journal article

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model

McNaughton, A, Lourenco, J, Hattingh, L, et al.
2019-02-21

4

Journal article

Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities.

Leitman, E, Palmer, C, Buus, S, et al.
2017-10-01

5

Journal article

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A

Harris, SA, Satti, I, Matsumiya, M, et al.
2014-06-30

6

Journal article

“It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome

Brown, P, Waite, F, Larkin, M, et al.
2022-02-16

7

Journal article

Rapid HIV disease progression following superinfection in an HLA-B27:05/B57:01-positive transmission recipient.

Brener, J, Gall, A, Hurst, J, et al.
2018-01-01

8

Journal article

Major TCR repertoire perturbation by immunodominant HLA-B*44:03-restricted CMV-specific T cells

Attaf, M, Malik, A, Severinsen, M, et al.
2018-11-14

9

Journal article

Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection

Adland, E, Millar, J, Bengu, N, et al.
2020-04-14

10

Journal article

The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens

van Diemen, P, Leneghan, D, Brian, I, et al.
2017-05-11

11

Journal article

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults

Sheehan, S, Harris, SA, Satti, I, et al.
2015-11-03

12

Journal article

Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia

Adland, E, Mori, L, Laker, L, et al.
2018-05-03

13

Journal article

HLA-B*14:02-Restricted Env-Specific CD8+ T-cell activity has highly potent antiviral efficacy associated with immune control of HIV infection

Leitman, E, Willberg, C, Tsai, M, et al.
2017-09-06

14

Journal article

Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape

Leitman, E, Thobakgale, C, Adland, E, et al.
2017-10-05

15

Journal article

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities

Hoang, U, de Lusignan, S, Joy, M, et al.
2022-05-18

16

Journal article

Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations

Malik, A, Adland, E, Laker, L, et al.
2017-12-12

17

Journal article

National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study

Hoang, U, de Lusignan, S, Joy, M, et al.
2022-03-31

TO TOP